ANRO — Alto Neuroscience Share News
0.000.00%
Last trade - 00:00- $887.66m
- $662.58m
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Brief: Alto Neuroscience - Proposed Resale Of Up To 6 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics
Brief: Alto Neuroscience Reports Topline Data From Phase 2 Proof-Of-Concept Study Of Alto-101 And Highlights Pipeline Advancements
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
Brief: Alto Neuroscience Announces $120 Million Private Placement Financing
Brief: Alto Neuroscience Reports Full Year 2025 Financial Results And Recent Business Highlights
Brief: Alto Neuroscience Announces Completion Of Enrollment In Phase 2 Proof-Of-Concept Study Of Alto-101
U.S. STOCKS ON THE MOVE-Arm Holdings, silver miners, Zions Bancorp
U.S. STOCKS ON THE MOVE-Apple, Zoom, Arm Holdings
Alto Neuroscience jumps after plans to accelerate depression drug development
U.S. STOCKS ON THE MOVE-Glaukos, Reddit, Micron
Alto Neuroscience rises after plans to accelerate depression drug development
U.S. STOCKS ON THE MOVE-Occidental Petroleum , GameStop, Alphabet
Brief: Alto Neuroscience Receives FDA Fast Track Designation For Alto-101
Alto Neuroscience climbs on FDA's 'fast track' tag for schizophrenia drug
Brief: Alto Neuroscience Announces Robust Replication Of EEG Biomarker
Brief: Alto Neuroscience Reports Positive Phase 2 Results for Alto-203, Identifies Biomarker
U.S. STOCKS ON THE MOVE-Guardant Health, Hewlett Packard Enterprise, Venture Global